Annual report pursuant to Section 13 and 15(d)

Capital Stock, Stock Plans, Warrants, and Stock Based Compensation (Tables)

v3.20.1
Capital Stock, Stock Plans, Warrants, and Stock Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of the options granted during 2019 and 2018 and the related assumptions used in the Black-Scholes option model used to value the options granted were as follows. No options were granted to employees in 2018:

 

    Employee Stock
    Option Granted
    2019
Weighted-average fair value per share   $1.46
Risk -free interest rate (1)   1.40%-2.58%
Expected volatility of stock (2)   48.67%-51.38%
Dividend yield   None
Expected option life (3)   5.0 years

 

    Outside Director Stock Options Granted  
    2019     2018  
Weighted-average fair value per share     $2.27       $2.87  
Risk -free interest rate (1)     2.08%       2.62%-2.98%  
Expected volatility of stock (2)     54.28%       55.34%-57.29%  
Dividend yield     None       None  
Expected option life (3)     10.0 years       10.0 years  

 

(1) The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option.

 

(2) The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option.

 

(3) The expected option life is based on historical exercises and post-vesting data.

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The following table summarizes stock-based compensation recognized for fiscal years 2019 and 2018.

 

    Year Ended  
    2019     2018  
Employee Stock Options   $ 150,000     $ 147,000  
Director Stock Options     29,000       51,000  
Total   $ 179,000     $ 198,000  

Schedule of Stock Options Roll Forward

The summary of the Company’s total plans as of December 31, 2019 and 2018, and changes during the period then ended are presented as follows:

 

    Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (years)     Aggregate Intrinsic Value (3)  
Options outstanding January 1, 2019     616,000     $ 4.23                  
Granted     129,500       3.24                  
Exercised     (32,400 )     4.10             $ 93,000  
Forfeited/expired     (31,800 )     8.68                  
Options outstanding end of period (1)     681,300     $ 3.84       4.2     $ 3,587,000  
Options exercisable as of December 31, 2019(1)     286,800     $ 4.28       3.8     $ 1,383,000  

 

    Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (years)     Aggregate Intrinsic Value (3)  
Options outstanding January 1, 2018     624,800     $ 4.42                  
Granted     18,000       4.22                  
Exercised     (10,000 )     3.65             $ 8,000  
Forfeited/expired     (16,800 )     11.70                  
Options outstanding end of period (2)     616,000     $ 4.23       4.7     $  
Options exercisable at December 31, 2018(2)     249,333     $ 5.04       4.4     $  

 

(1) Options with exercise prices ranging from $2.79 to $8.40

(2) Options with exercise prices ranging from $2.79 to $13.35

(3) The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price

Schedule of Non Vested Options

The summary of the Company’s nonvested options as of December 31, 2019 and changes during the period then ended are presented as follows:

 

          Weighted Average  
          Grant-Date  
    Shares     Fair Value  
Non-vested options January 1, 2019     366,667     $ 1.91  
Granted     129,500       1.53  
Vested     (90,667 )     2.02  
Forfeited     (11,000 )     1.60  
Non-vested options at December 31, 2019     394,500     $ 1.77